CD8A and myeloid sarcoma: CD8+ T cells have received less attention than CD4+ T cells in MS and EAE, but it is now well-established that CD8+ T cells are more activated in the periphery and can infiltrate active lesions, contributing to the increasing severity of MS symptoms (115, 116, 187).